Literature DB >> 20180065

[Risks and prevention of prostate cancer. Commentary on the new S3 guideline].

B J Schmitz-Dräger1, E Bismarck, G Lümmen.   

Abstract

Acceptance of prostate cancer as an endemic disease was the basis for the decision reached by the guideline committee to devote a chapter to the topic of risks and prevention of prostate cancer. Analysis of the substantial data regarding these subjects, however, shows that a number of apparently accepted risk factors and recommendations for prevention do not withstand subtle assessment. For this reason, only information concerning the risk factors of age and genetic predisposition is obtained from men. While the role of nutrition in the pathogenesis of prostate cancer remains beyond dispute, data on individual food items are very contradictory. Positive results of interventional studies are not available. Thus, the committee issued general recommendations on nutrition and lifestyle which also include other malignant tumors and the risk for cardiovascular disease. New findings of prospective studies on chemoprevention were incorporated into a statement. Since 5-alpha-reductase inhibitors have not yet been approved for prevention of prostate cancer, no recommendation was given.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180065     DOI: 10.1007/s00120-010-2240-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  29 in total

1.  Epidemiologic association between prostatitis and prostate cancer.

Authors:  Leslie K Dennis; Charles F Lynch; James C Torner
Journal:  Urology       Date:  2002-07       Impact factor: 2.649

2.  Meta-analysis of measures of sexual activity and prostate cancer.

Authors:  Leslie K Dennis; Deborah V Dawson
Journal:  Epidemiology       Date:  2002-01       Impact factor: 4.822

3.  Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.

Authors:  Norie Kurahashi; Motoki Iwasaki; Shizuka Sasazuki; Tetsuya Otani; Manami Inoue; Shoichiro Tsugane
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03-02       Impact factor: 4.254

4.  Height, body weight, and risk of prostate cancer.

Authors:  E Giovannucci; E B Rimm; M J Stampfer; G A Colditz; W C Willett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-08       Impact factor: 4.254

5.  Diet in the epidemiology of carcinoma of the prostate gland.

Authors:  S Graham; B Haughey; J Marshall; R Priore; T Byers; T Rzepka; C Mettlin; J E Pontes
Journal:  J Natl Cancer Inst       Date:  1983-04       Impact factor: 13.506

Review 6.  Lycopene: modes of action to promote prostate health.

Authors:  Karin Wertz; Ulrich Siler; Regina Goralczyk
Journal:  Arch Biochem Biophys       Date:  2004-10-01       Impact factor: 4.013

Review 7.  A systematic review and meta-analysis of familial prostate cancer risk.

Authors:  L E Johns; R S Houlston
Journal:  BJU Int       Date:  2003-06       Impact factor: 5.588

Review 8.  Five-alpha-reductase Inhibitors for prostate cancer prevention.

Authors:  T J Wilt; R MacDonald; K Hagerty; P Schellhammer; B S Kramer
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

9.  Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study.

Authors:  J R Hebert; T G Hurley; B C Olendzki; J Teas; Y Ma; J S Hampl
Journal:  J Natl Cancer Inst       Date:  1998-11-04       Impact factor: 13.506

10.  Diabetes mellitus and risk of prostate cancer: a meta-analysis.

Authors:  S Bonovas; K Filioussi; A Tsantes
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.